-+ 0.00%
-+ 0.00%
-+ 0.00%

Wolfe Research Downgrades Janux Therapeutics to Peer Perform

Benzinga·11/12/2026 15:50:08
Diffusion vocale
Wolfe Research analyst Kalpit Patel downgrades Janux Therapeutics (NASDAQ:JANX) from Outperform to Peer Perform.